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In a series of 301 renal homograft recipi· 
ents, 17 (5.6%) had acute pancreatitis at 
some time after transplantation. Eleven of 
these patients died, for a mortality of 64.7%. 
In each instance, pancreatitis was a major 
factor in a complex chain of lethal events to 
which immunosuppression invariably con· 
tributed. An additional 43 patients (14.3%) 
developed asymptomatic hyperamylasemia 
after transplantation and, undoubtedly, 
. some of these recipients also had pan· 
creatitis. The factors causing pancreatitis in 
the renal transplantation patient include 
uremia, hyperparathyroidism, pancreatic in· 
jury by drugs, infections resulting from 
chronic immunosuppression, gallstones, and 
operative trauma to the pancreas. In cases 
of preexisting pancreatitis, transplantation 
is not necessarily precluded, but efforts 
should be made to find a specific cause of 
the pancreatitis and take corrective mea· 
sures, such as biliary tract surgery or para· 
thyroi.dectomy if indicated, in advance of 
transplantation. 
A number of reports have appeared 
.i1. in the literature indicating that 
pancreatitis is a complication of re-
nal homotransplantation. I·_ However, 
many questions require clarification, 
including the incidence and causes of 
pancreatitis, the significance of hy-
peramylasemia in renal homograft 
recipients; the prognosis with post-
transplantation pancreatitis; and the 
outlook of patients with preexisting 
pancreatitis. In an attempt to answer 
Accepted for publication April 7, 1972. 
From the Department of Surgery, University 
of Colorado School of Medicine, and the Veterans 
Administration Hospital, Denver. Dr. Durst is 
now with Hadassah Hospital, Jerusalem, Israel. 
Dr. Machado is now with Universidade de Sao 
Paulo, Brazil. 
Read before the 29th annual meeting of the 
Central Surgical Association, Chicago, March 2, 
1972. 
Reprint requests to 1055 Clermont St, Denver 
80220 (Dr. Penn). 
Arch Surg/Vol105, Aug 1972 
some of these questions, 301 kidney 
recipients treated at the University 
of Colorado Medical Center and the 
Denver Veterans Administration 
Hospital were studied. 
Clinical Material 
The case records were reviewed of 301 
recipients of 362 renal homografts who 
were treated between November 1962 and 
January 1971. The patients were 3 to 57 
years of age; 207 were male and 94 were 
female. Two hundred thirty recipients ob-
tained their primary grafts from related 
donors, while unrelated living volunteers 
and cadavers were used in 31 and 40 in-
stances, respectively. Most of the grafts 
for retransplantation were from cadavers. 
Of the 301 recipients, 240 had trans-
abdominal bilateral nephrectomies and 
splenectomy done at the time of transplan-
tation. A few other patients had this oper-
ation at some time prior to or after the 
transplantation, while the remaining re-
cipients did not undergo the procedure. 
Immunosuppression was provided with 
prednisone and azathioprine (Imuran) in 
117 patients, and with these same two 
agents plus antilymphocyte globulin 
(ALG) in the remainder." 
Evidence of pancreatitis was sought for 
by the notation of suggestive symptoms 
and physical signs, radiologic changes, ele-
vation of the serum amylase level, lap-
arotomy findings, and autopsy reports. In 
addition, possible specific etiologic factors 
were looked for including operative trau-
ma to the pancreas, systemic infections, 
hyperparathyroidism, and gallbladder dis-
ease. 
In the majority of the patients, serum 
amylase levels were measured in either 
Caraway unitsR (normal, 60 to 160/100 ml) 
or iodometric units9 (normal, 45 to 150/100 
ml). Since the range of these units was 
very similar, the results will be used inter-
changeably for the purposes of this com-
munication. In a few indicated cases, 
Close-Street units") were used (normal, 6 to 
33/100 ml). 
Results 
Preexisting Pancreatitis.-In five pa-
tients (four males, one female; aged 
17 to 45 years) pancreatitis was diag-
nosed before or at the time of trans-
plantation (incidence 1.7%). One of 
these recipients had recurrent clinical 
and chemical signs of pancreatitis be-
fore the onset of renal failure. An-
other was found to have widespread 
fat necrosis and calcification in the 
pancreas at the nephrectomy and 
splenectomy six months before renal 
transplantation; a simultaneous find-
ing of gallstones prompted cholecys-
tectomy. In the third patient, who 
underwent bilateral nephrectomy 
concomitant with the transplanta-
tion, the tail of the pancreas was 
found necrotic and had to be removed. 
A fourth patient had several nearly 
fatal bouts of pancreatitis while un-
dergoing dialysis. Hyperparathy-
roidism was suspected and at explor-
atory operation hyperplastic glands 
were found and resected. Following 
this, pancreatitis did not recur and 
the patient underwent transplanta-
tion three months later. 
After transplantation, four of the 
above recipients had an uneventful 
early convalescence, although hyper-
amylasemia (236 to 1,010 units) oc-
curred. The first patient eventually 
developed very brittle diabetes mel-
litus for which he now requires 135 
units of insulin per day, 26 months af-
ter transplantation. The second and 
fourth recipients are well 16 and 13 
months after transplantation, respec-
tively. The third patient died of 
causes unrelated to pancreatitis 29 
months after transplantation. 
The final patient was treated in 
1963 with a cadaver kidney which 
never functioned. Abdominal pain 
and a serum amylase level of 850 
iodometric unitsllOO ml suggested a 
diagnosis of pancreatitis shortly be-
fore operation. The patient died of 
bronchopneumonia and uremia 25 
days later. At autopsy, the pancreas 
was fibrotic and infiltrated with his-
tocytes and lymphocytes. 
Pancreatitis Diagnosed After Trans-
plantation.-Definite Cases.-There 
were 12 patients (nine males, three 
females; aged 11 to 49 years, mean, 33 
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years) in whom pancreatitis was 
diagnosed from one day to 44 months 
after the transplantation, and then 
subsequently confirmed at either lap-
arotomy or autopsy (4%) (Table 1). In 
two instances, the pancreatitis was 
probably caused by injury to the tail 
of the pancreas during left nephrec-
tomy or splenectomy. Both of these 
patients had delayed distal pan-
createctomy but died with multiple 
intra-abdominal complications. A 
third patient was found to have a 
small abscess in the tail of the pan-
creas at autopsy. 
In the other· nine recipients, ne-
phrectomies and splenectomy had 
also been performed on the same day 
as transplantation. However, the cir-
cumstances of the pancreatitis were 
against the possibility that pan-
creatic injury had occurred during re-
moval of the organs. For example, the 
whole organ was involved in all nine 
recipients, and in eight of the pa-
tients it was months to years after 
operation when pancreatitis ap-
peared. 
Treatment was conservative in 
eight of the 12 patients. A ninth pa-
tient (Fig 1 and 2) required 
drainage of a very extensive retro-
peritoneal abscess which developed 
as a complication of pancreatitis. 
Figure 1 shows the first year's 
course of this 20-year-old woman fol-
lowing bilateral nephrectomy, sple-
nectomy, and renal transplantation 
from her mother. The pancreatitis 
was suspected because of complaints 
of upper abdominal pain, hyper-
amylasemia, and suggestive radio-
logic changes. Currently, the patient 
is at 72 months after transplantation 
Table I.-Summary Data on 12 Patients With Definite Pancreatitis 
After Renal Transplantation* 
No. of Cases 
Diagnosis established at 1 ~aparotomy Autopsy 
8 
Localization of lesions ~ ~hole pancreas Distal part only 
3 
Time of diagnosis after 1~1 mo 1 mo·1 yr >1 yr transplantation 4 4 
Serum amylase, highest {1200 units 200-1,000 units >1,000 units 
valuet 3 6 
Creatinine clearance at gone <40 ml/min >40 ml/min 
time of diagnosis 5 4 
Distal pancreatic 
Treatment of { ~onservative Drainage resection 
pancreatitis 1 3:1: 
Died with multiple 
Outcome i ~ecovered Died of pancreatitis complications 
5 6 
* All underwent bilateral nephrectomies and splenectomy concomitant with the trans-
plantation. 
t Caraway or iodometric units except in one case with a level of 1,370 Close-Street units. 
In two patients no amylase data are available. 
:I: In one of the patients the whole pancreas was diseased. 
with a. stable creatinine clearance of 
26 m1!min. The other three patients 
underwent distal pancreatic resec-
tions (Table 1). 
Pancreatitis in this group of 12 pa-
tients had a poor prognosi.s. It was 
the major cause of death or a signifi-
cant contributing factor in 11 pa-
tients, while the survivor had a 
stormy convalescence before she 
eventually recovered from the pan-
creatitis and its complications. 
Suspected Cases.-Five of the pa-
tients (three males, two females; 
aged 19 to 37 years) had suggestive 
clinical and laboratory findings of 
pancreatitis (1.7%). All had nephrec-
tomies and splenectomy at the time 
of transplantation. In two patients 
the disorder occurred within 4 and 11 
days of operation and could have been 
aggravated by operative trauma. In 
two cases the evidence of pancreatitis 
developed after seven weeks; it oc-
curred during a bout of acute hepa-
titis in one of the patients. In the fi-
nal case, the diagnosis was made 
during an episode of streptococcal 
septicemia five months after trans-
plantation. In two of the recipients, 
renal function was poor at the time of 
the suspected pancreatitis but in the 
other three it was satisfactory or 
good. The range for the highest se-
rum amylase value was 104 to 325 
iodometric units before the operation, 
and 400 to 3,500 units after the oper-
ation. All five patients are alive after 
follow-up studies ranging from 29 to 
78 months. 
If the 12 definite and five probable 
pancreatitis cases are pooled, the inci-
dence of postoperative pancreatitis in 
the 301 patients is 5.6%. 
Hyperamylasemia After Transplanta-
tion.-Forty-three (26 males and 17 
Table 2.-Findings in 43 Patients With Asymptomatic Hyperamylasemia After Renal Transplantation* 
Operation 
Bilateral 
nephrectomies and 
splenectomy, 
transplantation 
Transplantation 
only.!: 
* Range and mean values are given. 
t Caraway or iodometric units. 
No. of 
Cases 
27 
16 
Serum Amylase, Highest Value, Unitst 
, 
, , 
Before After 
Operation Operation 
75-678 300-5,500 
(225) (1,097) 
44-275 350-1,422 
(144) (872) 
Postoperative Hyperamylasemia 
, 
, 
Duration; Onset, Days 
After Operation Days 
1-18 1-69 
(4) (11) 
1-43 1-28 
(6) (8) 
:I: Eleven patients had undergone preliminary bilateral nephrectomies and splenectomy; two patients received second transplants 28 and 
74 months after having undergone the combined procedure; three patients never had nephrectomies and splenectomy. 
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Fig I.-In this patient, abscess in left labium majus was drained 75 days after transplantation <D . Sinogram demon· 
strated an extensive proximal extension of abscess (Fig 2), which was drained through incision. in left flankd>. Large 
retroperitoneal abscess arising from pancreas was drained 16 days later ~K All three abscesses communicateCl. Serum 
amylase level remained elevated for prolonged periods. Graft function deteriorated during treatment of abscesses. 
females; aged 10 to 44 years; mean, 26 
years) of the 301 patients had asymp-
tomatic hyperamylasemia during the 
postoperative period (14.3%) (Table 
2). In these recipients, hyperam-
ylasemia was very commonly pres-
,ent before operative intervention. 
Of the 240 patients that underwent 
the composite operation of bilateral 
nephrectomy, splenectomy, and renal 
homotransplantation on the same 
day, with the possibility of operative 
pancreatic trauma, 27 had significant 
elevations of serum amylase level 
(11.3%) (Table 2). Following the other 
122 transplantations where the kid-
neys and spleen were not removed 
concomitantly, there were 16 in-
stances of hyperamylasemia after 
transplantation (13.1%). In these 
cases, the possibility of injury to the 
pancreas at the time of transplanta-
tion was eliminated. The timing, 
magnitude, and duration of hyper-
amylasemia before and after trans-
plantation was similar to that in the 
group described above (Table 2). 
Among the 43 patients with asymp-
tomatic hyperamylasemia, 15 had ab-
sent or poor renal function at the 
time of the biochemical abnormal-
ities. Twelve of the 43 patients even-
tually died. Postmortem examination 
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in ten of these showed either a nor-
mal pancreas or insignificant histo-
logic changes. Autopsy was not per-
formed in the other two cases. 
Etiologic Associations.-Hypercal-
cemia and Hyperparathyroidism.-
Among the five patients with pre-
existing pancreatitis, hyperparathy-
roidism was demonstrated by oper-
ation in one. Four of the 12 patients 
with proven pancreatitis after trans-
plantation had elevated serum cal-
cium levels which ranged from 11 
mg/100 ml to 16.6 mg/100 ml and 
which spontaneously returned to nor-
mal in all but one instance. Ulti-
mately, all four of the patients died 
and autopsy was performed in three. 
Two of these three patients had para-
thyroid hyperplasia. 
In addition, five of the 43 patients 
with asymptomatic hyperamylasemia 
had postoperative hypercalcemia, 
with the maximum calcium concen-
tration being 16.3 mg/l00 ml. One of 
these latter recipients required an 
emergency parathyroidectomy for 
hyperplasia 46 days after transplan-
tation (Fig 3). Currently, this patient 
is at 46 months after transplantation, 
with normal serum amylase and cal-
cium levels. 
Gallstones.-One patient with pre-
existing pancreatitis, another with 
definite posttransplantation pan-
creatitis, and a third with asymp-
tomatic hyperamylasemia had gall-
stones. In the first and third in-
stances, the gallbladder was removed 
before transplantation at the time 
of nephrectomies. The other patient 
died of generalized sepsis and pan-
creatitis 44 months after transplanta-
tion and was found at autopsy to have 
a stone in the common bile duct. 
Systemic InfectWns.-Four cases of 
proven and one of suspected pan-
creatitis occurred during episodes of 
septicemia or fungemia; or both .. Only 
the patient with the suspected pan-
creatitis survived. 
Viral Hepatitis.-Two instances of 
proved and one of suspected acute 
pancreatitis became manifest during 
episodes of acute hepatitis. Two of 
the three patients died (Fig 4). The 
third recovered from the pancreatitis, 
but has had slowly deteriorating he-
patic function during the 81,2 years of 
life after transplantation. 
Comment 
In the first report of pancreatitis 
after renal homotransplantation,' 
there were three proven examples in 
42 consecutive recipients (7.1%), and 
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two additional suspected cases for a 
total incidence of 11.9%. In the pres-
ent series, which is an extension of 
the original one, there were 17 (5.6%) 
of 301 patients with proven or sus-
pected pancreatitis, as well as an-
other 43 (14.3%) with posttrans-
plantation hyperamylasemia. Such 
figures make it clear that pancreatitis 
is a very significant problem after re-
nal homotransplantation, and that it 
can be expected far more frequently 
than at the 2% incidence found in the 
survey of transplantation centers 
made by Johnson and Nabseth.' 
There are undoubtedly many fac-
tors that contribute to pancreatitis in 
the complex setting of clinical renal 
homotransplantation. To begin with, 
inflammatory changes in the pan-
creas have been said to be very com-
mon in uremia. [1-13 In the course of 
performing bilateral nephrectomy 
and splenectomy in our patients, it 
often has been noted that the pan-
creas is harder or larger than normal, 
and in three cases, definite evidence 
of old pancreatitis was found. 
Why uremia should cause pancrea-
titis is not known. One possible mech-
anism is by the secondary hyperpara-
thyroidism which is a well-recognized 
complication of chronic renal fail-
ure." In our patients, there were only 
three examples of the combination of 
proven hyperparathyroidism and pan-
creatitis, but more subtle forms of hy-
perparathyroidism than those associ-
ated with high serum calcium levels 
may have gone undiagnosed. 
After transplantation, the drugs 
that are administered probably playa 
far-reaching etiologic role and one 
which is not easily analyzable. Corti-
costeroids have been shown in rab-
bits",16 and man'2.17-'9 to produce pan-
creatitis and, in addition, this 
complication has been ascribed in iso-
lated cases to azathioprine20 and to 
the diuretic, chlorothiazide.'9 
Apart from their intrinsic toxicity 
to the pancreas, the immunosuppres-
sive agents required to control rejec-
tion could contribute to pancreatitis 
by predisposing to infection. Four of 
our proven and one of our suspected 
cases of pancreatitis occurred during 
septicemia or fungemia, or both. The 
association of pancreatitis with sys-
temic infections is recognized even in 
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Fig 2.-Sinogram demonstrating a tract 
(arrows) extending from left labium majus 
retroperitoneally into left flank. Same pa-
tient as Fig 1. 
patients who have not undergone im-
munosuppression. '2". 
Similarly, three of the proven or 
suspected cases of pancreatitis oc-
curred during a bout of hepatitis. The 
association of pancreatitis with hepa-
titis has been described by Blumen-
thal and Probstein[2 and Elliot and 
Williams."' In turn, it has recently 
been shown that acute and chronic 
hepatitis are very common in the pe-
riod after transplantation, to the ex-
tent that patients who have under-
gone long-term immunosuppression 
may actually represent a public 
health problem.22 
Under conditi{)ns of immunosup-
pression, chronic infestations with 
viruses in addition to the virus re-
sponsible for serum hepatitis has 
been well documented. Herpesvirus 
apd cytomegalovirus (CMV) have been 
particularly well studied.',23 Conceiv-
ably, there could be direct coloniza-
tion of the pancreas by such viruses. 
In two cases of posttransplantation 
pancreatitis reported by Tilney5 and 
van Geertruyden and Toussaint,6 the 
CMV virus was found in the organ at 
autopsy. Whether or not the microor-
ganism contributed to the develop-
ment of pancreatitis is speculative. 
The extent to which immunosup-
pression affects the outcome of pan-
creatitis after it is established is not 
known. On the one hand, one might 
hope that an "autoimmune compo-
nent," such as speculated upon by 
Thal,24-26 secondary to pancreatic tis-
sue, lllJUry would be minimized by 
host immunologic paralysis. On the 
other hand, Apostolou et al21 have 
suggested that host immune re-
sponses may help limit the disease of 
pancreatitis, perhaps by the elatJora-
tion of anti-enzyme antibodies. If this 
latter view were true, immunologic 
invalidism would be an adverse cir-
cumstance. The latter hypothesis 
would be consistent with the fact that 
11 of our 12 patients with proven pan-
creatitis died. This heavy mortality 
also characterized Johnson and Nab-
seth's compilation," in which more 
than half the patients died. 
In addition to the special metah9lic 
or pharmacologic factors that apply 
generally to posttransplantation pa-
tients, there were also examples of 
pancreatitis from a predominantly 
mechanical cause. In our series, gall-
stones probably were contributory in 
three patients. Injury to the tail of 
the pancreas was definitely respon-
sible for regional pancreatitis in two 
others. Finally, the asymptomatic hy-
peramylasemia, so commonly noted in 
our cases, may have been inadver-
tently caused during the nephrec-
tomies and splenectomy. A high 
incidence of amylase elevation has 
been noted in non immunosuppressed 
patients submitted to various kinds 
of upper-abdominal surgery!1.,",2. 
Against operative trauma beipg a 
common etiologic factor, however, is 
the finding that hyperamylasemia 
was equally frequent in those of our 
patients whose upper abdomen was 
not operated on at the time of trans-
plantation. Since retention of the en-
zyme occurs in renal failure30-34 poor 
graft function could have contributed 
to the elevated enzyme levels. 
Four of the five patients with pre-
existing pancreatitis survived after 
operation without any early complica-
tions directly attributable to the ab-
normal pancreas, although one of the 
recipients subsequently developed 
rather severe diabetes. These results 
may be fortuitous but they do indi-
cate that there are hopes for success, 
particularly if factors predisposing.to 
pancreatitis can be corrected. Condi-
tions that would be easily rectified in-
clude biliary tract disease and, possi-
bly, parathyroid hyperplasia. The 
avoidance of pancreatitis by these 
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Fig 3.-Course of 24·year·old woman who underwent bilateral nephrectomies, splenectomy, and renal transplantation from her father. Ma· 
jor asymptomatic rise in serum amylase level followed operation. One month after operation, enzyme levels returned to normal. Maximal am· 
ylase elevations occurred when renal function was poor. Hypercalcemia necessitated emergency parathyroidectomy 46 days after transplan· 
tation. 
Fig 4.-Course of Il·year·old girl who underwent transplantation for renal failure caused by cystinosis. Donor (maternal 
grandmother) developed hepatitis 30 days after operation. Forty·one days later the patient was readmitted with same 
diagnosis. Pancreatitis developed approximately 100 days after transplantation. Severe hypocalcemia (serum calcium 
level below 2.4 mEq/liter), marked metabolic acidosis, and falling hematocrit were observed. Patient died 109 days 
after transplantation. Autopsy confirmed presence of hepatitis and acute hemorrhagic pancreatitis with fat necrosis. 
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means prior to transplantation would 
seem particularly worthwhile since 
after transplantation there is little 
that can be done for suspected pan-
creatitis except to take pains that the 
diagnosis is correct and to provide 
general supportive care including an-
tibiotics. Reduction in the immuno-
suppressive therapy, particularly in 
the dosage of prednisone, should be 
considered. 
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Discussion 
VALLEE L. WILLMAN, MD, St. Louis: It 
seems a little unusual that azathioprine 
alone would do it. You have had experience 
with other people who get the same immu-
nosuppressive regimen other than for re-
nal transplantation. The question is, does 
hyperamylasemia of itself predispose to 
the histological characteristics you report. 
Is this perhaps due to a failure to clear am-
ylase from the serum,' or is there some-
thing specific going on in the pancreas? 
ISRAEL PENN, MD, Denver: Thank you, 
Dr. Willman. I have not encountered any 
reports of azathioprine, used for conditions 
other than organ transplantation, being 
responsible for cases of acute pancreatitis. 
Hyperamylasemia per se does not neces-
sarily signify acute pancreatitis as it is 
often a manifestation of retention of en-
zyme in the blood as the result of poor kid-
ney function. 
DR. WILLMAN: What about your liver 
transplants? You have a fair number of 
people who have had liver transplantation. 
DR. PENN: Yes, we have also encountered 
pancreatitis in some of our liver homograft 
recipients. Many of the etiologic factors 
existing in renal transplant patients are 
also present in these people, including drug 
therapy with corticosteroids, azathioprine, 
and chlorothiazide; systemic infections; 
and operative handling of the pancreas. 
However, hyperparathyroidism, and gall-
stones are usually absent, but uremia may 
play a role in patients presenting with 
some degree of hepatorenal failure. 
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